1. Home
  2. ATER vs BIVI Comparison

ATER vs BIVI Comparison

Compare ATER & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aterian Inc.

ATER

Aterian Inc.

HOLD

Current Price

$0.40

Market Cap

13.4M

ML Signal

HOLD

Logo BioVie Inc.

BIVI

BioVie Inc.

HOLD

Current Price

$1.37

Market Cap

13.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATER
BIVI
Founded
2014
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
13.3M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
ATER
BIVI
Price
$0.40
$1.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
196.0K
211.5K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
55.77
N/A
EPS
N/A
N/A
Revenue
$68,975,000.00
N/A
Revenue This Year
$16.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$1.06
52 Week High
$1.87
$7.75

Technical Indicators

Market Signals
Indicator
ATER
BIVI
Relative Strength Index (RSI) 20.28 40.23
Support Level N/A $1.22
Resistance Level $0.70 $1.73
Average True Range (ATR) 0.13 0.21
MACD -0.10 -0.08
Stochastic Oscillator 0.93 13.33

Price Performance

Historical Comparison
ATER
BIVI

About ATER Aterian Inc.

Aterian Inc is a consumer products company that operates through online retail channels, including Amazon, Walmart, Target, as well as its own direct-to-consumer websites. The company develops and manages a portfolio of owned brands, which are either internally incubated or acquired, offering products across multiple categories such as home and kitchen appliances, kitchenware, air quality appliances, health and beauty products, and essential oils. Its primary brands include Squatty Potty, HomeLabs, Mueller Living, PurSteam, Healing Solutions, and Photo Paper Direct. The company generates revenue mainly through the online sale of its consumer products, with substantially all sales derived from the Amazon U.S. marketplace.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: